Technology driven biopharma player with differentiated portfolio and global presence

Ranked one of the fastest growing and 12th largest pharma player in India
(*as per AIOCD-AWACS MAT Mar'21)

Developing India’s first indigenous mRNA vaccine for
COVID-19

Committed to ensure dedicated support in the fight against
COVID- 19

Commited to ensure dedicated support in the fight against COVID-19

Know More

Emcure Pharmaceuticals Limited was formed with the purpose and core belief of making Effective Medicines to Cure patients, helping them lead healthier lives

We are a fast growing Indian pharmaceutical company engaged in developing, manufacturing and marketing a broad range of biopharmaceutical products globally. Emcure’s differentiated product portfolio lends an unparalleled competitive advantage establishing its presence in all major therapies in the domestic market. With a presence in over 70 countries, Emcure’s goal is to constantly innovate and deliver affordable & high-quality healthcare solutions to people.

12th Largest Pharma Company in India
9,000+ Employees
70+ Countries with presence

Focus Areas

Emcure Pharmaceuticals Ltd. has established presence in key areas

Gynaecology
Cardiology
Anti-infective
Vitamins, minerals and nutrients
Diabetes
Anti-Retro Virals
Biologics
mRNA vaccine

Research and Development

Leveraging technology as the key differentiator in the mission to develop products that serve across diverse markets. Emcure’s in-house research and development capabilities span both chemistry and biologics providing a unique synergy to develop innovative solutions

Research and Development

Empowered by the strength of ~500 qualified scientists ably led by industry stalwarts: Dr Mukund Gurjar, Dr Sanjay Singh and Dr Deepak Gondaliya

Research and Development

Presence across 5 dedicated facilities focused towards API, formulation and biotechnology research

Read more

Our Presence

Emcure Pharmaceuticals is present in over 70 Countries through its network and distribution channels

India
Canada
Mexico
Peru
Brazil
Chile
UK
Netherlands
Germany
France
Italy
Croatia
Spain
Nigeria
South Africa
Kenya
Dubai
Kazakhstan
Russia/CIS
Myanmar
Vietnam
Philipines
Australia

Newsroom

August 5, 2021

Emcure Pharmaceuticals may come up with an IPO of Rs 4000 crore

Read more
August 5, 2021

Emcure Pharma invested 400 cr at Sanand plant

Read more
August 5, 2021

India likely to get first mRNA vax by year-end

Read more
July 30, 2021

Gennova to use mRNA tech to develop Vax for Zika,TB

Read more
July 29, 2021

Emcure Pharma strengthens its board, adds 4 Independent Directors

Read more
Placeholder Image

Life at Emcure

At Emcure, we believe that the success and growth of the company is in the hands of our people. Hence, we are committed towards nurturing talent and providing equal opportunities for their further development.

Join us
Placeholder Image

Uncondition Yourself

Women’s Health continues to be a topic discussed in hushed tones with irrational stigmas and taboos associated with it. This platform aims to share real-life experiences, break myths & taboos and highlight facts, to change the dismal statistics around women’s health.

explore